DXP Enterprises, Inc. (DXPE) Forms $33.90 Double Bottom; Repros Therapeutics Inc. (RPRX) Had 1 Bulls

Among 3 analysts covering Repros Therapeutics (NASDAQ:RPRX), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Repros Therapeutics had 5 analyst reports since August 20, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, October 30 by Ladenburg Thalmann. Ladenburg Thalmann upgraded Repros Therapeutics Inc. (NASDAQ:RPRX) on Wednesday, November 16 to “Buy” rating. The rating was downgraded by Bank of America on Friday, October 30 to “Underperform”. The stock has “Hold” rating by Brean Capital on Friday, October 30. The rating was upgraded by Zacks to “Hold” on Thursday, August 20. See Repros Therapeutics Inc. (NASDAQ:RPRX) latest ratings:

DXP Enterprises, Inc. (DXPE) formed double bottom with $31.53 target or 7.00% below today’s $33.90 share price. DXP Enterprises, Inc. (DXPE) has $589.58M valuation. The stock increased 1.16% or $0.39 during the last trading session, reaching $33.9. About 101,042 shares traded or 10.16% up from the average. DXP Enterprises, Inc. (NASDAQ:DXPE) has risen 200.39% since January 18, 2017 and is uptrending. It has outperformed by 183.69% the S&P500.

Investors sentiment increased to 0.58 in 2017 Q3. Its up 0.36, from 0.22 in 2017Q2. It increased, as 5 investors sold Repros Therapeutics Inc. shares while 7 reduced holdings. 3 funds opened positions while 4 raised stakes. 4.93 million shares or 2.43% less from 5.05 million shares in 2017Q2 were reported. State Street Corporation holds 0% or 13,551 shares. 11,541 are owned by Goldman Sachs Grp. Baldwin Brothers Ma holds 0% or 1,750 shares. California Public Employees Retirement reported 118,000 shares or 0% of all its holdings. Fmr Ltd Liability stated it has 1.49 million shares or 0% of all its holdings. Wells Fargo And Communications Mn has invested 0% in Repros Therapeutics Inc. (NASDAQ:RPRX). Northern Trust Corp has invested 0% in Repros Therapeutics Inc. (NASDAQ:RPRX). Renaissance Tech Lc has 1.12M shares for 0% of their portfolio. Virtu Lc holds 132,445 shares. Riverpoint Capital Management has invested 0% in Repros Therapeutics Inc. (NASDAQ:RPRX). Retail Bank Of New York Mellon, New York-based fund reported 21,773 shares. Blackrock Inc, New York-based fund reported 686,324 shares. Morgan Stanley has 2,372 shares for 0% of their portfolio. Northwestern Mutual Wealth Management invested 0% of its portfolio in Repros Therapeutics Inc. (NASDAQ:RPRX). Two Sigma Securities Limited Liability reported 10,962 shares.

It closed at $0.6626 lastly. It is down 73.82% since January 18, 2017 and is downtrending. It has underperformed by 90.52% the S&P500.

Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of various drugs to treat hormonal and reproductive system disorders for male and female in the United States. The company has market cap of $26.21 million. The Company’s product portfolio include Proellex that is in Phase III clinical trials for the treatment of symptoms associated with uterine fibroids, as well as in Phase II clinical trial for the treatment of endometriosis; and enclomiphene, a single isomer of clomiphene citrate, which is in Phase III clinical trials for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function. It currently has negative earnings.

Investors sentiment decreased to 1.45 in Q3 2017. Its down 0.60, from 2.05 in 2017Q2. It worsened, as 24 investors sold DXP Enterprises, Inc. shares while 23 reduced holdings. 15 funds opened positions while 53 raised stakes. 12.83 million shares or 0.64% more from 12.75 million shares in 2017Q2 were reported. Deutsche Commercial Bank Ag has invested 0% of its portfolio in DXP Enterprises, Inc. (NASDAQ:DXPE). Federated Invsts Pa has 0.01% invested in DXP Enterprises, Inc. (NASDAQ:DXPE). Goldman Sachs Grp owns 0% invested in DXP Enterprises, Inc. (NASDAQ:DXPE) for 72,513 shares. King Luther Cap Mngmt holds 0.12% or 447,710 shares in its portfolio. Nationwide Fund Advsrs accumulated 48,489 shares. Acadian Asset Ltd holds 0% of its portfolio in DXP Enterprises, Inc. (NASDAQ:DXPE) for 35,455 shares. Bnp Paribas Arbitrage Sa reported 8,346 shares. 283,990 were accumulated by Hancock Hldg Company. Moreover, Voya Invest Mngmt Llc has 0% invested in DXP Enterprises, Inc. (NASDAQ:DXPE) for 7,056 shares. Ameriprise Financial stated it has 265,256 shares or 0% of all its holdings. Price T Rowe Md has 0% invested in DXP Enterprises, Inc. (NASDAQ:DXPE). Rhumbline Advisers has 0% invested in DXP Enterprises, Inc. (NASDAQ:DXPE). Pnc Service Gp owns 426 shares. Systematic Financial Limited Partnership reported 50,925 shares. Tower Research Cap Lc (Trc) holds 0.01% in DXP Enterprises, Inc. (NASDAQ:DXPE) or 2,352 shares.